Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.

COPHAR is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Pharmacology and Drug Discovery (CRPHAR).

COPHAR divides the subject of pharmacology into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance. Themes include neurosciences; cardiovascular and renal; respiratory; musculoskeletal; cancer; immunomodulation; anti-infectives; new technologies; gastrointestinal; endocrine; and metabolic diseases.

The journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.

Expertise - Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.
Comprehensiveness - There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.
Impact - In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.


Selection of topics to be reviewed
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.

Reviews
Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.

Editorial Overview
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.

Ethics in Publishing: General Statement

The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

For more information, please refer to: https://www.elsevier.com/conflictsofinterest

review 

Editors-in-Chief
D. G. Trist
D. G. Trist
San Bonifacio, Italy
M. Williams
M. Williams
Columbus, Ohio, United States
Associate Editor
Musculoskeletal
M. Brotto
University of Texas at Arlington, College of Nursing and Health Innovation, Department of Graduate Nursing, Arlington, Texas, United States
Inflammation
F. DiVirgilio
F. DiVirgilio
University of Ferrara Department of Morphology Surgery and Experimental Medicine, Ferrara FE, Italy
Respiratory
C.P. Page
King's College London Sackler Institute of Pulmonary Pharmacology, London, United Kingdom
Anti-infectives
S. Sanchez
National Autonomous University of Mexico Institute of Biomedical Research, Ciudad de Mexico, Mexico
New technologies
A.G. Stewart
The University of Melbourne School of Biomedical Sciences, Melbourne, Australia
Gastrointestinal
T. Vanuytsel
University of Leuven TARGID (Translational Research Center for Gastrointestinal Disorders), Leuven, Belgium
Cardiovascular
L.E. Wold
The Ohio State University Department of Physiology and Cell Biology, Columbus, Ohio, United States
CNS
D.C. Bertrand
HiQScreen Sarl, Genève, Switzerland
Editorial Board
D. Amantea
Arcavacata di Rende, Italy
L. Annunziato
Napoli, Italy
G. Bagetta
Cosenza, Italy
S.M. Belcher
Raleigh, North Carolina, United States
L.A. Blackshaw
London, United Kingdom
A. Bril
Suresnes, France
G. Burnstock
London, United Kingdom
H. Cox
London, United Kingdom
A. Davenport
Cambridge, United Kingdom
S.J. Enna
S.J. Enna
Kansas City, Kansas, United States
J. Furness
Melbourne, Victoria, Australia
S. Garattini
Milano, Italy
B. Hirst
Newcastle Upon Tyne, United Kingdom
S. Johnston
London, United Kingdom
P. Paoletti
Paris, France
M. Perretti
London, United Kingdom
J.P.R. Pin
Montpellier, France
F. G. M. Russel, PharmD, PhD
Nijmegen, Netherlands
M. Spedding
Suresnes, France
D.A. Taylor
Greenville, North Carolina, United States
C.R. Triggle
Doha, Qatar
M.J.O. Wakelam
Cambridge, United Kingdom
J.K.L. Walker
Durham, North Carolina, United States
S. Ward
Bath, United Kingdom